CELH
Celsius Holdings, Inc.
CELH has the edge over SENEB overall, supported by stronger valuation and stronger modeled upside.
SENEB
Seneca Foods Corporation
SENEB trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SENEB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Healthy |
SENEB's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over SENEB in the historical PE scenario, which offers more potential upside but is not a forecast.
SENEB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.4x | $76.18 | -56% |
| Current | 9.7x | $173 | — |
| Fair | 10x | $179 | +3.4% |
| Expensive | 15x | $260 | +50% |
Historical ranges are pointers, not guarantees.
SENEB's PE is 9.7x, but its earnings don't support one, so it isn't a reliable read right now.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
SENEB Forward outlook
There aren't enough analyst estimates for SENEB to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
SENEB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $17.28 | +100% |
| Q2 2026 | $17.30 | +177% |
| Q1 2026 | $16.59 | +181% |
| Q4 2025 | $13.01 | +132% |
| Q3 2025 | $8.63 | +45% |
| Q2 2025 | $6.24 | -15% |
| Q1 2025 | $5.90 | -31% |
| Q4 2022 | $6.18 | -6.5% |
SENEB has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over SENEB on profitability, with a higher operating margin.
SENEB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $492.6M | +7.1% |
| Q2 2026 | $405.2M | +36% |
| Q1 2026 | $393.8M | +14% |
| Q4 2025 | $508.3M | +1.1% |
| Q3 2025 | $460M | +8.1% |
| Q2 2025 | $297.5M | -2.4% |
| Q1 2025 | $345.8M | +12% |
| Q4 2024 | $502.9M | +13% |
SENEB's revenue has grown year over year for five quarters in a row: $493M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.6% | -1.4 points |
| Q2 2026 | 6.5% | -1.3 points |
| Q1 2026 | 6% | +5.5 points |
| Q4 2025 | 12% | +6.7 points |
| Q3 2025 | 9% | +3.2 points |
| Q2 2025 | 7.8% | -0.5 points |
| Q1 2025 | 0.6% | -0.3 points |
| Q4 2024 | 5.1% | -1.8 points |
SENEB's operating margin was 7.6% last quarter, down 1.4 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
SENEB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$45.5M | -309% |
| Q2 2026 | $91.9M | +117% |
| Q1 2026 | $93.1M | +14% |
| Q4 2025 | $22.9M | -79% |
| Q3 2025 | $21.8M | -69% |
| Q2 2025 | $42.4M | +11% |
| Q1 2025 | $81.4M | +102% |
| Q4 2024 | $108.7M | +$215.9M |
SENEB has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
SENEB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -3K shares |
| 1 year | -1.3% | -88K shares |
| 3 years | -25% | -2.3M shares |
SENEB has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.7M |
| Q2 2026 | $1.4M |
| Q1 2026 | $8.5M |
| Q4 2025 | $2.8M |
| Q3 2025 | $1.1M |
| Q2 2025 | $3.8M |
| Q1 2025 | $786,000 |
| Q4 2024 | $814,000 |
SENEB spent $14M buying back its own shares over the past year, up 121% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over SENEB on leverage, with a lower net debt burden relative to earnings.
SENEB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.9x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 2.7x | Moderate |
| Q4 2024 | 3.5x | Elevated |
SENEB's net debt is less than a year of its operating earnings (EBITDA), down from 1.9 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
SENEB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.5 | Neutral |
| Stochastic | 15.3 | Oversold |
SENEB's weekly RSI is 53 (neutral) and its Stochastic is 15 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
SENEB PE vs Consumer Defensive Sector
| Metric | SENEB | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 19x | 50% below |
| PE % | 42 | 17 | 25 pts above |
SENEB has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
SENEB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $169.3 | 2% above |
| 20 week MA | $176.5 | 2.1% below |
| 50 week MA | $151.6 | 14% above |
| 100 week MA | $123.9 | 40% above |
| 200 week MA | $89.3 | 94% above |
SENEB has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
SENEB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.0 | $39.5 | -3.7% |
| 2021 | $39.5 | $46.6 | +18% |
| 2022 | $46.6 | $63.0 | +35% |
| 2023 | $63.0 | $51.7 | -18% |
| 2024 | $51.7 | $79.4 | +54% |
| 2025 | $79.4 | $114.5 | +44% |
| 2026 YTD | $114.5 | $172.8 | +51% |
SENEB has the edge over CELH on returns for 2026, with the stronger performance.